Clinical Trials
66 trialsSANGUINE
JaxBio Ltd
PRODIGE
University Hospital, Brest
CASTETTE
University Hospital, Brest
CARPEDIEM
University Hospital, Brest
REVIEW
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Gruppo Italiano Malattie EMatologiche dell'Adulto
BCR-ABL1
Siriraj Hospital
MPL - NPM
Centre Hospitalier Universitaire de Nīmes
TIRE
Imperial College Healthcare NHS Trust
Angioedema Biomarker Research Study
Foundation For Rare Disease Research
FIBROMOELLE
Assistance Publique - Hôpitaux de Paris
A Registry for Patients With Systemic Mastocytosis in China
The First Affiliated Hospital of Soochow University
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Alliance for Clinical Trials in Oncology
Carotid Plaque Burden in Patients With Philadelphia Negative Myeloproliferative Neoplasms
Sohag University
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis.
Sohag University
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
Assiut University
DALY-MAST
University Hospital, Toulouse
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Center for International Blood and Marrow Transplant Research
Iclusig PMS in CML or Ph+ALL Patients
Korea Otsuka Pharmaceutical Co., Ltd.
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
Beijing Friendship Hospital
QoL-PV-R
Multinational Center for Quality of Life Research, Russia
Characteristics of Patients With Philadelphia Negative Myeloproliferative Neoplasms at Assiut University Hospital
Assiut University
SPACE2
Weprom
CML1012
Gruppo Italiano Malattie EMatologiche dell'Adulto
CML1113
Gruppo Italiano Malattie EMatologiche dell'Adulto
Case-Only
Nanfang Hospital, Southern Medical University
Mascot
Royal Free Hospital NHS Foundation Trust
Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem Cells
Nanfang Hospital, Southern Medical University
TIGIT in Patients With Chronic Myeloid Leukemia
Assiut University
Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms
Assiut University
MCD&BuDi
University Hospital, Toulouse
Allogeneic SCT for CML, TKI Failure After TKI Failure
University Health Network, Toronto
Anticoagulation in Gastroesophageal Varices and JAK2 Mutation
Shanghai Zhongshan Hospital
Gastroesophageal Varices in Cavernoma
Shanghai Zhongshan Hospital
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
Maastricht University
Value of CD26 Positive Leukemic Stem Cell in Myeloproliferative Neoplasm
Assiut University
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
M.D. Anderson Cancer Center
Symptom Burden in Chronic Myeloid Leukemia (CML)
M.D. Anderson Cancer Center
Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
Seoul St. Mary's Hospital
Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase Inhibitor
Assiut University
Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response
Ankara University
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
National Taiwan University Hospital
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
GREFFE
Hospices Civils de Lyon
The Hong Kong CML Registry
The University of Hong Kong
QoL-CML0713
Gruppo Italiano Malattie EMatologiche dell'Adulto
CTIM3
Assistance Publique - Hôpitaux de Paris
CML-SLEEP
HaEmek Medical Center, Israel
LMC
Institut Bergonié
Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization
Seoul St. Mary's Hospital